BIOMAT Database Logo BIOMAT Database Logo

Antiandrogenic treatment of obsessive-compulsive neurosis. 1986

M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané

UI MeSH Term Description Entries
D009771 Obsessive-Compulsive Disorder An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension. Anankastic Personality,Neurosis, Obsessive-Compulsive,Anankastic Personalities,Disorder, Obsessive-Compulsive,Disorders, Obsessive-Compulsive,Neuroses, Obsessive-Compulsive,Neurosis, Obsessive Compulsive,Obsessive Compulsive Disorder,Obsessive-Compulsive Disorders,Obsessive-Compulsive Neuroses,Obsessive-Compulsive Neurosis,Personalities, Anankastic,Personality, Anankastic
D003534 Cyproterone An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females. Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D017373 Cyproterone Acetate An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites. Androcur,Cyproterone Acetate, (1 alpha,2 alpha)-Isomer,Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer,Cyproterone Acetate, (17 alpha)-Isomer

Related Publications

M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
Antiandrogenic treatment for obsessive-compulsive disorder.
March 2000, The American journal of psychiatry,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
[Treatment of obsessive compulsive neurosis].
March 1985, Harefuah,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
Treatment of obsessive-compulsive neurosis.
September 1970, Canadian Medical Association journal,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
Treatment of obsessive-compulsive neurosis.
September 1970, Canadian Medical Association journal,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
Behavioral treatment of obsessive-compulsive neurosis.
January 1979, Behaviour research and therapy,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
Obsessive compulsive neurosis.
May 1987, Xianggang hu li za zhi. The Hong Kong nursing journal,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
Obsessive compulsive neurosis.
February 1978, The Practitioner,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
Treatment of obsessive compulsive neurosis: pharmacological approach.
January 1976, Psychosomatics,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
Treatment of obsessive--compulsive neurosis with haloperidol.
July 1970, Canadian Medical Association journal,
M Casas, and E Alvarez, and P Duro, and C Garcia-Ribera, and C Udina, and A Velat, and D Abella, and J Rodriguez-Espinosa, and P Salva, and F Jané
The treatment of chronic obsessive-compulsive neurosis.
August 1971, Behaviour research and therapy,
Copied contents to your clipboard!